Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 0904-7010

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 0904-7010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

959e2dcf 530b 43f3 9916 23c16ccc2c50 00

This is a description of a medication called Buprenorphine and Naloxone Sublingual Tablets USP used for the treatment of opioid addiction. The tablets are administered sublingually and come in a unit dose package with a warning for use only under the supervision of a healthcare provider. The dosage strength is 8 mg/2 mg, and the medication is available only with a prescription. The text also provides a National Drug Code (NDC) number for the product.*

FDA Label Image

959e2dcf 530b 43f3 9916 23c16ccc2c50 01

This is a description of a prescription medication called Buprenorphine and Naloxone Sublingual Tablets USP. The tablets are for oral use and include 2mg of buprenorphine and 0.5mg of naloxone. The medication guide emphasizes the importance of keeping the tablets out of reach of children and warns that accidental ingestion could be a medical emergency. The usual dosage and safety information are provided, along with a unique product identification number (NDC 0904-7009-06). Overall, the text contains important information for anyone prescribed this medication.*

FDA Label Image

Buprenorphine-medguide-graphic.jpg (Buprenorphine Medguide Graphic)

FDA Label Image

Image 02

FDA Label Image

Naloxone-chem-figure.jpg (Naloxone Chem Figure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.